Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
AstraZeneca
Kivu Bioscience Inc.
AstraZeneca
Tubulis GmbH
Eli Lilly and Company
EMD Serono
Arcus Biosciences, Inc.
Sumitomo Pharma America, Inc.
Terremoto Biosciences Inc.
Bristol-Myers Squibb
Radiopharm Theranostics, Ltd
Seagen Inc.
Bayer
Radiopharm Theranostics, Ltd
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Exscientia AI Limited
Normunity AccelCo, Inc.
Eli Lilly and Company
Poseida Therapeutics, Inc.
MacroGenics
SystImmune Inc.
Boundless Bio, Inc.
Eli Lilly and Company
AbbVie
Radiopharm Theranostics, Ltd
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Innate Pharma
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Var2 Pharmaceuticals
OncoNano Medicine, Inc.
GlaxoSmithKline
Fate Therapeutics
Compass Therapeutics
Tanabe Pharma America, Inc.
NeoTX Therapeutics Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
Pfizer
OncoHost Ltd.
BicycleTx Limited
Volastra Therapeutics, Inc.
AbbVie
Nanobiotix
Immunitas Therapeutics
Janux Therapeutics